123 related articles for article (PubMed ID: 15109416)
1. Neutralizing antibodies and Sin Nombre virus RNA after recovery from hantavirus cardiopulmonary syndrome.
Ye C; Prescott J; Nofchissey R; Goade D; Hjelle B
Emerg Infect Dis; 2004 Mar; 10(3):478-82. PubMed ID: 15109416
[TBL] [Abstract][Full Text] [Related]
2. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
Hooper JW; Josleyn M; Ballantyne J; Brocato R
Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection.
Valdivieso F; Vial P; Ferres M; Ye C; Goade D; Cuiza A; Hjelle B
Emerg Infect Dis; 2006 Jan; 12(1):166-8. PubMed ID: 16494739
[TBL] [Abstract][Full Text] [Related]
4. Rapid and simple method for screening wild rodents for antibodies to Sin Nombre hantavirus.
Yee J; Wortman IA; Nofchissey RA; Goade D; Bennett SG; Webb JP; Irwin W; Hjelle B
J Wildl Dis; 2003 Apr; 39(2):271-7. PubMed ID: 12910753
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of antibody-bound and unbound Sin Nombre virus in the plasma of patient with hantavirus pulmonary syndrome.
Terajima M; Ennis FA
J Virol Methods; 2003 Jun; 110(2):159-62. PubMed ID: 12798243
[TBL] [Abstract][Full Text] [Related]
6. Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein.
Velappan N; Martinez JS; Valero R; Chasteen L; Ponce L; Bondu-Hawkins V; Kelly C; Pavlik P; Hjelle B; Bradbury AR
J Immunol Methods; 2007 Apr; 321(1-2):60-9. PubMed ID: 17336997
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune responses in the hantavirus cardiopulmonary syndrome.
Bharadwaj M; Nofchissey R; Goade D; Koster F; Hjelle B
J Infect Dis; 2000 Jul; 182(1):43-8. PubMed ID: 10882580
[TBL] [Abstract][Full Text] [Related]
8. Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome.
MacNeil A; Comer JA; Ksiazek TG; Rollin PE
J Infect Dis; 2010 Jul; 202(2):242-6. PubMed ID: 20521946
[TBL] [Abstract][Full Text] [Related]
9. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
Xiao R; Yang S; Koster F; Ye C; Stidley C; Hjelle B
J Infect Dis; 2006 Nov; 194(10):1403-9. PubMed ID: 17054070
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model.
Medina RA; Mirowsky-Garcia K; Hutt J; Hjelle B
J Gen Virol; 2007 Feb; 88(Pt 2):493-505. PubMed ID: 17251568
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of serological assays for detection of human hantavirus infections caused by Sin Nombre virus.
Schmidt J; Meisel H; Hjelle B; Krüger DH; Ulrich R
J Clin Virol; 2005 Jul; 33(3):247-53. PubMed ID: 15911448
[TBL] [Abstract][Full Text] [Related]
12. Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses.
Warner BM; Stein DR; Jangra RK; Slough MM; Sroga P; Sloan A; Frost KL; Booth S; Chandran K; Safronetz D
Viruses; 2019 Jul; 11(7):. PubMed ID: 31337019
[TBL] [Abstract][Full Text] [Related]
13. Experimental Infection of Peromyscus Species Rodents with Sin Nombre Virus.
Quizon K; Holloway K; Iranpour M; Warner BM; Deschambault Y; Soule G; Tierney K; Kobasa D; Sloan A; Safronetz D
Emerg Infect Dis; 2022 Sep; 28(9):1882-1885. PubMed ID: 35997624
[TBL] [Abstract][Full Text] [Related]
14. Delayed density-dependent prevalence of Sin Nombre virus antibody in Montana deer mice (Peromyscus maniculatus) and implications for human disease risk.
Madhav NK; Wagoner KD; Douglass RJ; Mills JN
Vector Borne Zoonotic Dis; 2007; 7(3):353-64. PubMed ID: 17767405
[TBL] [Abstract][Full Text] [Related]
15. Elevated cytokines, thrombin and PAI-1 in severe HCPS patients due to Sin Nombre virus.
Bondu V; Schrader R; Gawinowicz MA; McGuire P; Lawrence DA; Hjelle B; Buranda T
Viruses; 2015 Feb; 7(2):559-89. PubMed ID: 25674766
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of immune responses in deer mice experimentally infected with Sin Nombre virus.
Schountz T; Acuña-Retamar M; Feinstein S; Prescott J; Torres-Perez F; Podell B; Peters S; Ye C; Black WC; Hjelle B
J Virol; 2012 Sep; 86(18):10015-27. PubMed ID: 22787210
[TBL] [Abstract][Full Text] [Related]
17. A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.
Brocato RL; Hammerbeck CD; Bell TM; Wells JB; Queen LA; Hooper JW
J Virol; 2014 Jan; 88(2):811-9. PubMed ID: 24198421
[TBL] [Abstract][Full Text] [Related]
18. Increased detection of Sin Nombre hantavirus RNA in antibody-positive deer mice from Montana, USA: evidence of male bias in RNA viremia.
Bagamian KH; Towner JS; Mills JN; Kuenzi AJ
Viruses; 2013 Sep; 5(9):2320-8. PubMed ID: 24064796
[TBL] [Abstract][Full Text] [Related]
19. Removing deer mice from buildings and the risk for human exposure to Sin Nombre virus.
Douglass RJ; Kuenzi AJ; Williams CY; Douglass SJ; Mills JN
Emerg Infect Dis; 2003 Mar; 9(3):390-2. PubMed ID: 12643840
[TBL] [Abstract][Full Text] [Related]
20. Long-term dynamics of Sin Nombre viral RNA and antibody in deer mice in Montana.
Kuenzi AJ; Douglass RJ; Bond CW; Calisher CH; Mills JN
J Wildl Dis; 2005 Jul; 41(3):473-81. PubMed ID: 16244056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
